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ABSTRACT 
 
 In 2010 New York passed state legislation that required providers to offer HIV 
testing and linkage to care to all patients aged 13-64 years seeking routine medical care in 
all settings, including emergency departments and hospitals. Previous studies have looked 
at the effect of the 2010 HIV testing law on testing volume and HIV diagnoses, but have 
not examined how the state policy affects acute care utilization and outcomes.  
A differences-in-differences regression model was developed using hospital 
discharge records collected from New York and Florida by the Healthcare Cost and 
Utilization Project from 2008-2012. The model evaluated whether the presence of the 
2010 HIV testing law in New York has had an effect on HIV-related hospital admissions 
in the two years before and after its implementation, using Florida as a comparison.  
The results of our analysis indicate that the 2010 HIV testing law decreased the 
percentage of hospital admissions that were HIV-related by 0.07 percentage points, when 
controlling for patient characteristics in addition to state, hospital and year effects. 
Although statistically significant, the small magnitude of the estimated effect suggests 
that state policymakers seeking to reduce acute care utilization for patients with HIV 
should supplement such laws with other policies or funding programs. These might 
include support for either more effective implementation of the mandate or programs that 
provide outreach, support, and treatment for HIV patients. Future studies should examine 
the long-term effects of the HIV testing law on acute care utilization or look at the effect 
on utilization of services in outpatient settings.
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BACKGROUND 
 According to the Centers for Disease Control and Prevention (CDC), there are 
over 1.2 million people in the United States living with human immunodeficiency virus 
(HIV) infection. If left unscreened and untreated, HIV infection leads to progressive 
failure of the human immune system, also referred to as acquired immune deficiency 
syndrome (AIDS), which increases the risk of life-threatening opportunistic infections 
and disease. This has an effect on acute care utilization in the United States, as 
individuals who are positive for HIV infection (HIV+) make emergency department (ED) 
visits at a higher annual rate and are more than two times as likely to be admitted into a 
hospital than individuals without HIV infection.
1
 
 Although there is no cure for HIV infection, adherence to current anti-retroviral 
treatments can suppress HIV viral loads and prevent HIV-related morbidity and mortality. 
However, diagnosis and linkage to care for HIV+ patients is still a major public health 
issue in the United States. The CDC estimates that only 60% of HIV+ individuals in the 
United States have been tested and linked to at least one visit for HIV care.
2
 
 One proposed intervention to improve outcomes for HIV patients is the routine 
offering of rapid HIV tests in EDs and the subsequent linking of newly diagnosed HIV+ 
patients to outpatient HIV care. In a study performed from January 2005 to March 2006, 
the CDC integrated rapid HIV testing into the healthcare services routinely offered at 
three EDs in Los Angeles, New York, and Oakland and found that 56% of patients that 
were offered an HIV test provided voluntary opt-in consent, and 88% of patients newly 
diagnosed with HIV were linked to care, defined as the patient receiving at least one 
medical follow-up visit specifically for HIV care and treatment.
3
 As a result of this study, 
the CDC decided in 2006 to make revisions to their clinical recommendations encourage 
healthcare providers to incorporate routine opt-out HIV testing in all health care settings.
4
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 Following the changes in CDC recommendations, the New York state legislature 
passed the 2010 HIV testing law, an amendment that extended public health law to 
mandate that all providers in New York (1) offer a voluntary HIV test to all patients aged 
13-64 years seeking care in any healthcare setting, and (2) link patients with follow-up 
care if they test HIV+. Effective September 2010, the legislation also relaxed informed 
consent requirements by allowing providers to include opt-out HIV testing into general 
medical consent.
5
 
 New York is the first and currently the only state to have implemented a law with 
a provider mandate to offer testing and linkage to care to patients with HIV infection. The 
intent of the law raises questions about the role of legislative mandates and whether they 
are an effective tool for governments and other public health institutions to encourage 
healthcare providers to follow nationally accepted clinical guidelines for managing HIV 
infection. While other evaluations have looked at the implementation of the 2010 HIV 
testing law and its effect on the incidence of HIV diagnoses in New York and confirmed 
increases in overall HIV testing volume, no study has yet looked at whether the law has 
resulted in improvements in the quality and efficiency of health care delivery for patients 
with HIV, which is the ultimate goal of HIV testing laws.
6
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RESEARCH QUESTION 
 This paper seeks to identify the effect of the 2010 HIV testing law on HIV-related 
hospital admissions for patients aged 13-64 in New York. Our hypothesis is that there 
should be a reduction in HIV-related hospital admissions after the implementation of the 
HIV testing law in 2010, as more providers in New York comply with the law to screen 
patients for HIV infection and refer HIV+ patients to outpatient settings for routine HIV 
care and treatment. 
 One method for analyzing the causal effect of the 2010 HIV testing law on HIV-
related admissions in New York is a differences-in-differences analysis. This approach 
compares the trend of hospital admissions for patients with HIV-infection in New York 
before and after the policy change, relative to the same periods of time for a state that did 
not implement a similar law. One state that serves as an ideal control for New York is 
Florida (FL), which had kept strict informed consent restrictions for HIV testing and did 
not implement a mandate for routine testing and linkage to care for HIV (Table 1).  
Table 1. Comparison of HIV policies for New York and Florida from 2008-2012. 
 
2008 –2010 
(pre-HIV testing law) 
2011 –2012 
(post-HIV testing law) 
NY 
 No routine HIV testing 
 Informed consent to test required 
 Mandatory routine HIV testing and 
linkage to care  
 General medical consent, opt-out  
FL 
 No routine HIV testing 
 Informed consent to test required 
 No routine HIV testing 
 Informed consent to test required 
  
Florida was also chosen as the comparison state because it (1) data was available 
for the study period, (2) it has a relatively large population, and (3) it is not a close 
distance to New York, which reduces the likelihood of a treatment contamination effect 
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where patients from Florida seek care in New York, which could bias the estimated effect 
of the HIV testing policy towards the null. 
In this study we sought to analyze the differences in the differences in HIV-
related admissions between NY and FL in the time periods before (2008-2010) and after 
(2011-2012) the policy change. Because of the presence of the HIV testing law, we 
would expect providers to be more vigilant in testing and linking patients to care in New 
York for HIV at greater rates than providers treating patients in Florida. This used to 
identify the legislative mandate in NY as the mechanism by which trends in HIV-related 
hospitalizations change relative to Florida. 
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DATA DESCRIPTION 
 This paper uses data from the State Inpatient Databases from the Healthcare Cost 
and Utilization Project (HCUP), which is a collection of longitudinal databases 
maintained by the Agency for Healthcare Research and Quality (AHRQ) that contain 
encounter-level information on all inpatient discharges from short-term, acute care, 
nonfederal, general, and other specialty hospitals in participating states. 
 The data elements collected in HCUP databases are built from hospital 
administrative data, such as hospital billing records, and contain data elements on patient 
admission (e.g. dates of admission, source of admission and type of admission), patient 
characteristics (e.g. age, sex, race and zip code), International Classification of Diseases, 
Ninth Revision, Clinical Modification (ICD-9-CM) procedures and diagnoses, and 
hospital identifiers. 
 In this study we used 2008-2012 hospital discharge data from New York and 
Florida. To capture the treatment effect and limit outliers in hospital admissions, we 
limited discharge records to those for which the age of the patient at admission was 
between 13 and 64 years and the length of stay was not greater than 20 days to reduce the 
influence of outliers.After selecting the records that met the inclusion criteria, we then 
identified the percentage of admissions that were HIV-related in New York and Florida 
for each year by creating a new variable to indicate the presence of either a “V08” ICD-9-
CM diagnosis code for asymptomatic HIV infection status or a “042” ICD-9-CM 
diagnosis code for symptomatic HIV disease as a primary or secondary diagnosis listed 
on the record.
7
 Records were also marked as HIV-related if they contained a single-level 
Clinical Classification Software diagnosis category level of “5,” which the AHRQ uses to 
classify hospital records containing diagnoses or procedure codes indicating that the 
admitted patient has symptomatic or asymptomatic HIV infection.
8
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STATISTICAL ANALYSIS 
 The following regression was performed, with an HIV-related hospital admission 
(HIVADMIT) as the binary outcome variable and presence of the 2010 HIV testing law 
at the date of admission (POLICY) as the determinant of interest: 
𝐻𝐼𝑉𝐴𝐷𝑀𝐼𝑇 = 𝛽1𝑃𝑂𝐿𝐼𝐶𝑌 + 𝛽2𝐹𝐸𝑀𝐴𝐿𝐸 + 𝛽3𝐴𝐺𝐸𝐺𝑅𝑂𝑈𝑃 + 𝛽4𝑅𝐴𝐶𝐸 + 𝛽5𝑃𝐴𝑌1
+ 𝐹𝐸𝑠𝑡𝑎𝑡𝑒 + 𝐹𝐸𝑦𝑒𝑎𝑟 + 𝐹𝐸ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙 + 𝜀 
Patient demographic characteristics such as age, gender, race, and primary insurer 
at admission were also included as explanatory variables in the regression analysis. The 
measure for patient gender (FEMALE) was an indicator variable for whether or not the 
patient is female or male.  
The measure for patient age at admission (AGEGROUP) was a categorical 
variable with values matching the three patient age groups affected by the HIV testing 
law: (1) adolescents 13-17 years of age, (2) adults 18-44 years of age, and (3) older adults 
45-64 years of age.   
Patient race (RACE) was a categorical variable with values indicating if the 
patient identified as: (1) white, (2) black, (3) Hispanic, (4) Asian and Pacific Islander, (5) 
Native American or (6) mixed or other group not listed. Finally, the variable for patient 
payer (PAY1) indicates the primary expected source of payment listed in the record: (1) 
Medicare, (2) Medicaid, (3) Private, (4) Self-pay, (5) No charge and (6) Other. 
 Indicator variables for state (FEstate), year (FEyear), and hospital (FEhospital) fixed 
effects were also included in the regression model to control for state and hospital 
influences on HIV admissions that were independent of time, as well as temporal trends. 
 Linear probability models were used for estimation. Although this overlooks the 
binary nature of our outcome, estimates should be consistent with logit models due to the 
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very large sample size.
9
 Three fixed effects models were used for estimation with the 
explanatory variables: (1) with just the policy variable, (2) the policy variable with 
patient characteristics, and (3) the second model with the addition of the primary payer 
included as an explanatory variable. All statistical analyses were conducted using 
Stata/MP version 14.1 (StataCorp). 
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RESULTS 
Characteristics of New York and Florida hospital admissions before and after the 
HIV testing law policy change appear in Table 2. In New York, there were 4,005,451 
admissions in the 3 years from 2008 to 2010 and 2,586,229 hospital admissions in the 2 
years after the 2010 HIV testing policy was passed and implemented. In Florida, there 
were 3,797,780 admissions in the pre-period and 2,573,973 admissions in the post-period. 
Table 2. Characteristics of New York and Florida hospital admissions from 2008-2012. 
 New York Florida 
 
2008 –2010 
pre-period 
(n = 4005451) 
2011 –2012 
post-period 
(n = 2586229) 
2008 –2010 
pre-period 
(n = 3797780) 
2011 –2012 
post-period 
(n = 2573973) 
Sex (n, %)     
Female 2361618 (59.0) 1521819 (58.8) 2287880 (60.2) 1525142 (59.3) 
Age (n, %)     
13-17 yrs 166900 (4.2) 99801 (3.9) 173052 (4.6) 111336 (4.3) 
18-44 yrs 1946154 (48.6) 1237781 (47.9) 1752849 (46.2) 1163227 (45.2) 
45-64 yrs 1892397 (47.2) 1248647 (48.3) 1871879 (49.3) 1299410 (50.5) 
Race (n, %)     
White 2014499 (50.3) 1244084 (48.1) 2254979 (59.4) 1486914 (57.8) 
Black 789824 (19.7) 543771 (21.0) 870048 (22.9) 545298 (21.2) 
Hispanic 540975 (13.5) 441109 (17.1) 605297 (15.9) 386164 (15.0) 
Other 660153 (16.5) 357265 (13.8) 67456 (1.8) 155597 (6.0) 
Payer (n, %)     
Medicare 446956 (11.1) 312598 (12.1) 569844 (15.0) 444558 (17.3) 
Medicaid 1390420 (34.7) 975852 (37.7) 916290 (24.1) 693625 (26.9) 
Private 1724216 (43.0) 1078506 (41.7) 1540655 (40.6) 904602 (35.1) 
Other 443859 (11.1) 219273 (8.5) 770991 (20.3) 531188 (20.6) 
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There were no significant changes in age or sex composition for either New York 
or Florida admissions in the pre and post period (Table 2). However, there were 
differences in changes in the racial composition of admissions between New York and 
Florida, namely that the proportion of admissions of Black and Hispanic patients 
increased over the study period in New York (from 19.7% to 21.0% and 13.5% to 17.1%, 
respectively; P < 0.001), but decreased over the study period in Florida (from 22.9% to 
21.2% and 15.9% to 15.0%, respectively; P < 0.001). Additionally, there were changes in 
the composition of payers between the two states, with Florida experiencing a greater 
decrease in the proportion of privately insured patient admissions (from 40.6% to 35.1%; 
P < 0.001) and a greater increase in the proportion of Medicare patients being admitted to 
the hospital (from 15.0% to 17.3%; P < 0.001) over the study period. 
To first visually determine if there was a change in the outcome between the two 
states across the study period, unadjusted trends of HIV-related admissions for New York 
and Florida are shown in Figure 1. 
 
 
Figure 1. HIV-related hospital admissions in New York and Florida from 2008-2012. 
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 Both New York and Florida experienced decreases in the number of HIV-related 
hospital admissions during the study period, however the unadjusted trends indicate that 
New York experienced a steeper downward trend in HIV-related admissions in the period 
after the 2010 HIV testing law was implemented. The trend in HIV-related admissions 
for Florida appears to level off in the post-period, relative to the trend seen for New York. 
Table 3. Difference-in-difference regression of the NY HIV testing law on HIV-related 
hospital admissions in New York and Florida from 2008-2012. 
  Model 1 Model 2 Model 3 
  coefficient p-value coefficient p-value coefficient p-value 
Policy -0.0014 (0.00) -0.0009 (0.00) -0.0007 (0.00) 
Sex       
Female -- -- -0.0157 (0.00) -0.0161 (0.00) 
Age group 
      
13-17 yrs -- -- -0.0191 (0.00) -0.0194 (0.00) 
18-44 yrs  -- -- (referent) -- (referent) -- 
45-64 yrs -- -- 0.0082 (0.00) 0.0075 (0.00) 
Race 
      
White -- -- (referent) -- (referent) -- 
Black -- -- 0.0410 (0.00) 0.0366 (0.00) 
Hispanic -- -- 0.0099 (0.00) 0.0059 (0.00) 
Asian/PI -- -- -0.0072 (0.00) -0.0088 (0.00) 
Native Am -- -- -0.0015 (0.01) -0.0029 (0.00) 
Mixed/Other -- -- 0.0058 (0.00) 0.0053 (0.00) 
Payer 
      
Medicare -- -- -- -- 0.0257 (0.00) 
Medicaid -- -- -- -- 0.0229 (0.00) 
Private -- -- -- -- (referent) -- 
Self-pay -- -- -- -- 0.0003 (0.04) 
No charge -- -- -- -- 0.0001 (0.84) 
Other -- -- -- -- 0.0075 (0.00) 
Constant 0.0251 (0.00) 0.0214 (0.00) 0.0137 (0.00) 
*All models include state, year and hospital fixed effects. 
Results of the difference-in-differences regression models are shown in Table 3. 
Controlling for other factors, presence of the NY HIV testing law reduced the percentage 
of hospital admissions that were HIV-related by 0.07 percentage points (p < 0.001). 
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DISCUSSION 
 The regression estimates from our analysis suggest that the 2010 NY HIV testing 
law had a statistically significant effect on reducing HIV-related hospital admissions in 
New York. However, the results also suggest that the magnitude of the effect is not 
clinically significant. 
In order to rule out that the decreases in HIV-related hospital admissions in New 
York and Florida were not simply due to population changes, the number of people living 
with HIV infection was examined using data from the CDC. Since 2008, the CDC has 
published an annual HIV/AIDS Surveillance Report, which provides a standardized 
national overview on the current epidemiology of HIV infection and disease in the United 
States.
10
 The surveillance reports uses data from state and territorial health departments, 
which have implemented systems to collect HIV diagnoses reported to them on a 
confidential name-based basis. A line graph of CDC-estimated prevalence for HIV 
infection in New York and Florida during the study period is shown in Figure 2. 
 
 
Figure 2. Prevalence of HIV diagnoses in New York and Florida from 2008-2012. 
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 The number of people living with diagnosed HIV infection did not change 
substantially for either New York or Florida during the study period. This magnitude of 
change suggests that the decrease in HIV-related admissions was not due to decreases in 
the number of people diagnosed with HIV. Prevalence of diagnosed HIV infection 
decreased slightly between the pre and post periods for New York, but magnitude does 
not appear large enough to explain the decline in HIV-related admissions in New York in 
Figure 1. Similarly, the prevalence of diagnosed HIV infection increased slightly for both 
New York and Florida from 2011 to 2012, but New York still experienced a steeper 
decline in HIV-related admissions. This result suggests that the decline in New York was 
due to an exogenous effect like the HIV testing policy change and not due to unobserved 
changes in HIV prevalence. 
 There are several limitations to this study that might explain the results. First, 
unobserved factors could have influenced hospitalization rates. For example, hospital 
admissions are difficult to predict and there are many scenarios, such as patients being 
admitted that do not reside locally and are difficult to link to proper outpatient care, 
which are outside the control of the provider. A better outcome to examine may be the 
rates of hospital readmission for patients diagnosed with HIV, for which the policy 
treatment would likely have a greater effect than on overall admissions of HIV patients. 
However, there are several limitations in the data arising from concerns over 
confidentiality of HIV patients the HCUP State Inpatient Databases, such as missing 
values for certain patient identifiers, such as income levels, residential zip codes and  
variables for linking patients with records of readmission.
11
 
 Secondly, the data may not be granular enough. As a result of patient privacy, the 
HCUP State Inpatient Databases for New York and Florida only provided the year of 
admission for HIV patients and not the exact date. Especially because the HIV testing 
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policy was not passed until September of 2010, it is possible that the pre-period (2008-
2010) and post-period (2011-2012) for this study were not long enough to capture the 
policy effect. 
 Third, the policy effect could be limited due to imperfect implementation around 
provider uptake and enforcement of HIV testing and linkage to care protocols. A 2012 
study sent electronic surveys to 191 emergency departments (EDs) across New York and 
found that only 65% of EDs offered HIV testing to all patients aged 13-64 as required by 
the law and only 29% of EDs could confirm linkage to care for patients testing positive 
for HIV infection.
12
 As a result of the limited implementation, the actual impact of the 
HIV testing law is likely limited during our study period. 
In addition to limitations of the study design, unobserved differences in the 
characteristics of patients in New York and Florida that changed during the study period 
could have confounded the estimated policy effect from the difference in differences 
models. As noted earlier, the proportion of admissions of Black and Hispanic patients 
increased for New York but decreased for Florida from the pre-period to the post-period. 
Similarly, Florida experienced a greater decrease in the proportion of patients admitted 
with private insurance than New York. Differential changes in the racial composition and 
payers between patients in New York and Florida could be indicative of unobserved 
changes in patient case-mix.  
Changes in insurance coverage that differ between New York and Florida are 
particularly concerning given the passage of the Affordable Care Act in 2010, which 
included Medicaid expansion. However, New York already had eligibility requirements 
higher than the federal mandate prior to the passage of the Affordable Care Act and 
Florida decided not to expand their income eligibilities for Medicaid.
13
 Therefore, 
Medicaid expansion is unlikely to have influenced our estimates. 
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 Lastly, there are other policy effects that differ between New York and Florida 
over time and might have had confounding effects on outcomes related to HIV care and 
treatment. In particular, over the last decade New York has implemented several 
initiatives to combat HIV/AIDS, which may be different from initiatives implemented by 
Florida, and could have affected HIV-related hospital admission rates. Also important to 
consider are federal initiatives and other grant programs related to HIV care and 
treatment that may have been distributed differentially between New York and Florida. 
For example, the Ryan White Program, a federal program first enacted in 1990 that 
provides funding to cities, states and other nonprofit entities to deliver healthcare and 
support services to medically underserved patients that are affected by HIV disease, 
provided Florida with $227 million in cumulative funding as of the end of September 
2015, but also provided New York with $322 million in cumulative funding.
14
 These 
policy differences could also explain the small estimated effect of the 2010 HIV testing 
law on HIV-related admissions in New York.  
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CONCLUSION 
 The passage of the 2010 NY HIV testing law was a monumental and largely 
unprecedented effort by the New York state government to address the epidemic of HIV 
infection. Although difficult to enforce, New York’s legislative mandate to providers to 
follow CDC clinical guidelines for HIV testing, care and treatment signaled a change in 
the way providers were expected to care for patients with HIV/AIDS, a patient population 
that has long experienced a history of stigma, mistreatment and clinical misinformation.  
Indeed, this study finds that the passage of the 2010 NY HIV testing law alone 
reduced hospital admissions that were HIV-related by 0.07 percentage points. 
While the legislative mandate itself was unfunded and at no direct cost to the New 
York state government budget, the requirement of providers following the mandate to 
increase testing has several downstream costs. A prospective cohort study performed in a 
Denver ED from 2007 to 2009 found that non-targeted HIV screening, like that 
recommended by the CDC in 2006 and mandated by the NY HIV testing law, resulted in 
an incremental cost of $10,693 per additional diagnosed infection, with most of the 
additional costs stemming from increased personnel time and increased HIV testing and 
blood draw supplies.
15
 An additional simulation study found that a nationwide adoption 
of the 2006 CDC recommendations for HIV testing and care would cost $2.7 billion over 
five years, with most of the additional costs stemming from the additional demand for 
government discretionary funding for HIV care.
16
 
Therefore, while the HIV testing law was responsible for a small decrease in the 
percentage of HIV-related admissions in New York, state policymakers seeking to 
improve delivery of care and outcomes for patients with HIV may find a state-wide 
provider mandate for HIV testing and linkage to care to be a limited solution and should 
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supplement such laws with other policies or funding programs to support implementation 
of the law, or redirect it to more effect interventions for HIV patients. 
Future studies on evaluating the HIV testing law may want to look at policy 
effects on outcomes in ambulatory and outpatient care rather than acute inpatient care. 
Additional studies may also want to look at long-term effects of the policy as compliance 
increases. 
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